Authors


Madeline King, PharmD

Latest:

The 5 Topics Every Infectious Disease Learner Should Read About, At Least Once!

In the latest Bench to Bedside column, clinicians provide information and resources on recommended topics learners should explore.



Mackenzie Keintz, MD

Latest:

Invasive Nontyphoidal Salmonellosis: An Antimicrobial-Resistant Foe

Salmonella becomes more dangerous as antimicrobial resistance grows. Read about its most common manifestations.


David Pitrak, MD

Latest:

Lessons in Resilience: What HIV Teaches Us About COVID-19

Four lessons learned from the AIDS crisis that can be applied to the fight against our current pandemic.


Hugh Davis, MD

Latest:

Final Diagnosis: Donor-Derived Staphylococcus Iugdunensis Endocarditis of Transplanted Heart

"This case gives uncomfortable insight into a gap in early detection of infections in immunocompromised, high-risk patient populations. "


Caleb C. McLeod, PharmD

Latest:

Cefiderocol’s Role in Managing Carbapenem-Resistant Acinetobacter baumannii Infections

This agent is likely best utilized as part of a combination when treating this bacterium but data regarding appropriate combinations are scarce.


Meagan Mayo, DO

Latest:

Pulmonary Coinfection With C neoformans and C immitis: A Novel Fungal Cohabitation

A patient presented with a history of uncontrolled HIV and a history of polysubstance use.


Jessica Irish, PharmD Candidate

Latest:

Need for Speed: Rapid Antiretroviral Initiation in the Emergency Department

Emergency departments (EDs) are an important entry point into the health care system and have been identified as a location with opportunity for increased HIV diagnosis and management.


Bennett Waxse, MD, PhD

Latest:

Improving Screening, Management of Hepatitis C in Infants and Children

Despite hepatitis C (HCV) incidence rates increasing, adequate screening for the virus continues to be a pressing challenge for public health officials.



Scott Curry, MD

Latest:

Exploring the Recently Approved and Upcoming Clostridioides difficile Therapeutics

This market has seen a flurry of activity, as shown by a review of the latest agents.


Myriam Shaw Ojeda, PharmD

Latest:

Assisting With International Health Care Needs

Although the pandemic halted many medical mission assignments, these opportunities and others are becoming available to help those geographic areas with acute needs.


Gerard Jacinto, PharmD

Latest:

Should Cefazolin be Prescribed in Patients With B-lactam Allergies?

For patients undergoing surgery, looking at the potential benefits of this antimicrobial for prophylaxis.


Meghan Lyman, MD

Latest:

Candida auris: Coming Soon to a Facility Near You?

Epidemiologic and clinical lessons for the uninitiated.


Amy L. Carr, PharmD, BCIDP

Latest:

The Next Generation of COVID-19 Vaccines and Boosters

Will there be an answer to keep the continuously evolving virus at bay? Are seasonal combination vaccines the wave of the future?


Kyle H. Lee

Latest:

That’s Not Appropriate: A Look at Antibiotic Prescribing Post Discharge

Extending antimicrobial stewardship programs to transition of care and discharge may prove beneficial to reduce unnecessary antibiotic use.


Jacinda C. Abdul-Mutakabbir, PharmD, MPH, AAHIVP

Latest:

Practice Pearls for Treatment of Respiratory Infections

Tina Tan, MD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Priya Nori, MD; Jacinda Abdul-Mutakabbir, PharmD; and Kevin Michael Reiter, MD, PA, provide key takeaways from the discussion on the treatment of respiratory viral infections.


Sophia Abene

Latest:

Top 5 Infectious Disease News Stories Week of July 19-26

This week, NYC has revealed high rates of Hepatitis C virus reinfection, SHEA tackles antimicrobial resistance amidst challenges during the COVID-19 pandemic, and more this week from Contagion.


Marissa Cavaretta, PharmD, BCPS, BCACP

Latest:

Sticking It to COVID-19: The Expansion of the Pfizer-BioNTech Vaccine EUA

A review of the data and circumstances that led to authorization in children ages 5 to 11 years.


Kelly Cawcutt, MD, MS, FACP, FIDSA, FCCM

Latest:

Opposing Forces During COVID-19: Perspective From the ICU

Conflicting priorities of infection control, antimicrobial stewardship, and critical care make the management of sepsis secondary to SARS-CoV-2 infection challenging.


Maureen McElligott, MD

Latest:

Opposing Forces During COVID-19: Perspective From the ICU

Conflicting priorities of infection control, antimicrobial stewardship, and critical care make the management of sepsis secondary to SARS-CoV-2 infection challenging.


Sandra Perreand, MBA

Latest:

Lifting the Medical and Economic Burden of AMR in the US

This bipartisan initiative highlights the need for a comprehensive approach to combat antimicrobial resistance (AMR), incorporating both antibiotic drug development and increased funding for stewardship programs.


Elysia Burke, PharmD

Latest:

Febrile Finesse: Are We Employing Appropriate Empiric Coverage in Patients With Neutropenic Fever?

Traditional therapy coverage does not include recent data that offers some updates in evaluating the current effectiveness of empiric antibiotic treatment.


Audry Hawkins, PharmD

Latest:

SHARE the Responsibility of Antibiotic Stewardship With Our Patients

How pharmacists can use shared decision-making to improve antibiotic use.


Andrew Skinner, MD

Latest:

Key Takeaways on FMTs in the Treatment of CDI

Experts provide practice pearls for educating patients on and using FMTs for the management of CDI.



Alexandra L. Cunha, PharmD

Latest:

The Next Generation of COVID-19 Vaccines and Boosters

Will there be an answer to keep the continuously evolving virus at bay? Are seasonal combination vaccines the wave of the future?


Caroline Teter, PA-C

Latest:

Lessons in Resilience: What HIV Teaches Us About COVID-19

Four lessons learned from the AIDS crisis that can be applied to the fight against our current pandemic.


Meredith Oliver PharmD, BCIDP

Latest:

Expanded Treatment Options for Multi-Drug Resistant Infections in Children

In the latest article from SIDP, here is a look at therapy options addressing this emerging clinical challenge.


Jason Chao, PharmD; and Nicola Clayton, PharmD, BCID

Latest:

How Do You Measure the Success of Your Stewardship Program?

The challenging search for a metric that effectively evaluates an ASP’s direct impact on appropriate antimicrobial use and improved patient outcomes.

© 2024 MJH Life Sciences

All rights reserved.